0001728117-21-000025.txt : 20210301 0001728117-21-000025.hdr.sgml : 20210301 20210301165400 ACCESSION NUMBER: 0001728117-21-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210225 FILED AS OF DATE: 20210301 DATE AS OF CHANGE: 20210301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Salter-Cid Luisa CENTRAL INDEX KEY: 0001766404 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38796 FILM NUMBER: 21698857 MAIL ADDRESS: STREET 1: C/O GOSSAMER BIO, INC. STREET 2: 3013 SCIENCE PARK ROAD, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gossamer Bio, Inc. CENTRAL INDEX KEY: 0001728117 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 475461709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3013 SCIENCE PARK CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 922-0718 MAIL ADDRESS: STREET 1: 3013 SCIENCE PARK CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wf-form4_161463558108922.xml FORM 4 X0306 4 2021-02-25 0 0001728117 Gossamer Bio, Inc. GOSS 0001766404 Salter-Cid Luisa 3013 SCIENCE PARK ROAD SAN DIEGO CA 92121 0 1 0 0 Chief Scientific Officer Common Stock 2021-02-25 4 A 0 45000 0 A 211556 D Stock Option (Right to Buy) 9.79 2021-02-25 4 A 0 90000 0 A 2031-02-25 Common Stock 90000.0 90000 D Represents restricted stock unit award, which will vest in three equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date. Includes 32,641 shares subject to forfeiture, which shares will vest in equal monthly installments as set forth in the restricted stock agreement between the Issuer and Reporting Person so that all of the shares will be released from the forfeiture restriction on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Also includes 46,500 restricted stock units granted in February 2020, which shares will vest in three equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date. 25% of the total number of shares subject to the option will vest on February 25, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. /s/ Jeff Boerneke, Attorney-in-Fact 2021-03-01